CSI Market
Sign In | Register

Qsam Biosciences Inc (APGR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access APGR Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Qsam Biosciences Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent1.39
Cash & Short-term Investments1.00
Other Current Assets0.25
Prepaid Expense And Other Assets Current0.07
Total Current Assets1.71
Other Assets, Noncurrent0.00
Subscription Receivable-
Subscription Receivable Current-
Total Assets1.71
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.57
Dividends Payable, Current IN0.46
Other Notes Payable, Current OT0.00
Other Liabilities, Current0.01
Total Current Liabilities1.03
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities1.03
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock41.67
Retained Earnings / Accumulated Deficit-40.16
Defined Benefit Plan and Other-1.35
Other Equity-0.51
Common Stockholder's Equity-0.35
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.51
Total Stockholder's Equity0.16
Liabilities & Stockholder's Equity1.71
4 historic quarters locked

Sign in to unlock the full Qsam Biosciences Inc balance sheet history.

Sign In Create Free Account

About Qsam Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: March 20, 2024
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-24-010683

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.